Safety, tolerability, and immunogenicity of inactivated trivalent seasonal influenza vaccine administered with a needle-free disposable-syringe jet injector

Article ID	Journal	Published Year	Pages	File Type
10968041	Vaccine	2011	7 Pages	PDF

Abstract

âº This report is the first in human assessment of a newly licensed jet injector LectraJet® M3 RA. âº Administration of seasonal influenza vaccine using the jet injector was well tolerated. âº The jet injector induced immune responses that were similar to needle and syringe.

Keywords

URI SAE CBC TIV FDA CDC DSJI GMT CHMP EMEA Influenza United States Agency for International Development European Medicines agency Global Alliance for Vaccines and Immunization U.S. Food and Drug Administration Safety Immunogenicity Program for Appropriate Technology in Health Jet injection USAID World Health Organization complete blood count adverse event Intramuscular Upper respiratory infection Serious adverse event confidence interval not applicable Centers for Disease Control and Prevention Path hemagglutination inhibition geometric mean titers Millimeter HBV Hepatitis C virus HCV Vaccine human immunodeficiency virus HIV hepatitis B virus WHO GAVI